Page last updated: 2024-09-04

atazanavir sulfate and AIDS Seroconversion

atazanavir sulfate has been researched along with AIDS Seroconversion in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldin, G; Belmonti, S; Borghetti, A; Ciccullo, A; De Luca, A; Di Giambenedetto, S; Emiliozzi, A; Gagliardini, R; Lamonica, S; Lombardi, F; Montagnani, F; Moschese, D; Visconti, E1
Atrio, J; Cherala, G; DuBois, BN; Stanczyk, FZ1
Abgrall, S; Bucher, H; Cain, LE; Caniglia, EC; Casabona, J; Costagliola, D; Dabis, F; Esteve, A; Fehr, J; Hernán, MA; Jarrín, I; Jose, S; Justice, A; Logan, R; Meyer, L; Muga, R; Olson, A; Paparizos, V; Pérez-Hoyos, S; Phillips, A; Reiss, P; Robins, J; Rubio, R; Sabin, C; Seng, R; Sterne, JAC; Tate, J; Touloumi, G; van Sighem, A; Vandenhende, MA1
Beniowski, M; De Wit, S; Gatell, J; Kirk, O; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P; Sedlacek, D1
Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; Di Perri, G; Gonzalez de Requena, D; Siccardi, M; Simiele, M; Tettoni, M; Trentini, L1
Ananthakrishnan, S; Garg, A; Levine, D1
Aubry, C; Badens, C; Javelle, E; Oliver, M; Savini, H; Simon, F1
Bower, M; Dunning, J; Manley, K; Nelson, M1
Carman, T; Hileman, C; Labbato, DE; Longenecker, C; McComsey, G; Milne, G; Storer, Nj; White, C1
Bassetti, D; Castagna, A; De Pascalis, CR; Fusetti, G; Galli, A; Gianotti, N; Guffanti, M; Lazzarin, A; Seminari, E1
Acinapura, R; Antinori, A; Liuzzi, G; Marconi, P; Sette, P; Trotta, MP; Zaccarelli, M; Zinzi, D1
Coleman, CI; White, CM1

Trials

1 trial(s) available for atazanavir sulfate and AIDS Seroconversion

ArticleYear
Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.
    Contraception, 2015, Volume: 91, Issue:1

    Topics: Adolescent; Adult; Atazanavir Sulfate; Contraceptives, Oral, Synthetic; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; HIV Protease Inhibitors; HIV Seropositivity; Humans; Metabolic Clearance Rate; Norethindrone; Oligopeptides; Progestins; Pyridines; Radioimmunoassay; Ritonavir; Up-Regulation; Young Adult

2015

Other Studies

11 other study(ies) available for atazanavir sulfate and AIDS Seroconversion

ArticleYear
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
    BMC infectious diseases, 2019, Jan-17, Volume: 19, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Ritonavir; Tenofovir; Treatment Outcome; Viral Load

2019
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
    Medicine, 2016, Volume: 95, Issue:41

    Topics: Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; United States; Viral Load

2016
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
    AIDS (London, England), 2010, Jul-17, Volume: 24, Issue:11

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Disease Progression; Epidemiologic Methods; Female; Glomerular Filtration Rate; HIV Seropositivity; HIV-1; Humans; Indinavir; Kidney Failure, Chronic; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir

2010
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
    Antiviral therapy, 2011, Volume: 16, Issue:4

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome

2011
Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:4

    Topics: Adenine; Adrenal Insufficiency; Adult; Atazanavir Sulfate; Cushing Syndrome; Cytochrome P-450 Enzyme Inhibitors; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Iatrogenic Disease; Injections, Intramuscular; Lamivudine; Oligopeptides; Organophosphonates; Pruritus; Pyridines; Ritonavir; Tenofovir; Triamcinolone Acetonide

2011
Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
    AIDS (London, England), 2012, Jan-14, Volume: 26, Issue:2

    Topics: Adult; Anti-HIV Agents; Asian People; Atazanavir Sulfate; Gilbert Disease; Glucosephosphate Dehydrogenase Deficiency; HIV Seropositivity; Humans; Hyperbilirubinemia; Male; Oligopeptides; Pyridines

2012
HIV-associated gastric natural killer/T-cell lymphoma.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:1

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Atazanavir Sulfate; Cyclophosphamide; Doxorubicin; Female; HIV Seropositivity; Humans; Lamivudine; Lymphoma, Extranodal NK-T-Cell; Oligopeptides; Prednisone; Pyridines; Pyrrolidinones; Raltegravir Potassium; Stomach Neoplasms; Vincristine

2012
Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy.
    HIV medicine, 2012, Volume: 13, Issue:10

    Topics: Adult; Atazanavir Sulfate; Bilirubin; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Cell Adhesion Molecules; Cross-Sectional Studies; Endothelium, Vascular; F2-Isoprostanes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Protease Inhibitors; HIV Seropositivity; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Oligopeptides; Oxidative Stress; Pyridines; Retrospective Studies; Tumor Necrosis Factor-alpha; Vasodilation

2012
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
    AIDS (London, England), 2003, Dec-05, Volume: 17, Issue:18

    Topics: Adult; Atazanavir Sulfate; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Female; Furans; HIV Protease Inhibitors; HIV Seropositivity; Humans; Male; Middle Aged; Oligopeptides; Pilot Projects; Pyridines; Reverse Transcriptase Inhibitors; Sulfonamides; Treatment Outcome

2003
Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.
    Journal of acquired immune deficiency syndromes (1999), 2005, May-01, Volume: 39, Issue:1

    Topics: Atazanavir Sulfate; HIV Seropositivity; HIV-Associated Lipodystrophy Syndrome; Humans; Oligopeptides; Pyridines; Switzerland; Treatment Failure; Treatment Refusal

2005
A comparison of different protease inhibitors on coronary heart disease risk.
    Connecticut medicine, 2007, Volume: 71, Issue:1

    Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Clinical Trials as Topic; Coronary Disease; HIV Protease Inhibitors; HIV Seropositivity; Humans; Hyperlipidemias; Nelfinavir; Oligopeptides; Pyridines; Risk Factors

2007